SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma

Clinical trial NCT07254585 · RECRUITING

Trial details

NCT number: NCT07254585
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2025-12-18
Primary completion: 2026-06-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.